We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$224M
Cap. Flow
-$309M
Cap. Flow %
-22.53%
Top 10 Hldgs %
17.96%
Holding
216
New
21
Increased
69
Reduced
53
Closed
28

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$29M
2
MXCT icon
MaxCyte
MXCT
+$14.8M
3
SKIN icon
SkinHealth Systems
SKIN
+$8.7M
4
JBTM
JBT Marel
JBTM
+$7.82M
5
EXE
Expand Energy Corp
EXE
+$7.8M

Top Sells

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$25.1M
2
INSP icon
Inspire Medical Systems
INSP
+$21.2M
3
TXG icon
10x Genomics
TXG
+$21.1M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20.2M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$13.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.81%
2 Technology 14.81%
3 Financials 9.02%
4 Industrials 8.86%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
26
Insulet
PODD
$9.79B
$14.2M 1.04%
50,100
-21,654
-30% -$6.18M
KTB icon
27
Kontoor Brands
KTB
$4.26B
$13.7M 1%
274,124
+4,067
+2% +$225K
EXE
28
Expand Energy Corp
EXE
$21.5B
$13.5M 0.99%
219,545
+139,212
+173% +$7.8M
BBIO icon
29
BridgeBio Pharma
BBIO
$16.5B
$13.4M 0.98%
286,132
-165,850
-37% -$8.89M
KRYS icon
30
Krystal Biotech
KRYS
$9.66B
$13.4M 0.98%
256,875
-56,579
-18% -$3.35M
VEEV icon
31
Veeva Systems
VEEV
$37.4B
$13.3M 0.97%
46,243
-23,367
-34% -$7.42M
GS icon
32
Goldman Sachs
GS
$303B
$13.2M 0.97%
35,000
-17,961
-34% -$7.01M
AMRS
33
DELISTED
Amyris Inc.
AMRS
$13M 0.95%
946,366
-302,412
-24% -$4.33M
FRC
34
DELISTED
First Republic Bank
FRC
$13M 0.95%
67,358
+11,391
+20% +$2.24M
DMTK
35
DELISTED
DermTech, Inc. Common Stock
DMTK
$12.9M 0.94%
400,308
+34,375
+9% +$1.21M
BAC icon
36
Bank of America
BAC
$442B
$12.7M 0.93%
300,000
+30,000
+11% +$1.21M
ARES icon
37
Ares Management
ARES
$30.9B
$12.6M 0.92%
170,000
– –
XOM icon
38
ExxonMobil
XOM
$634B
$12.4M 0.9%
210,000
-5,000
-2% -$285K
CZR icon
39
Caesars Entertainment
CZR
$6.14B
$12.3M 0.9%
109,572
+118
+0.1% +$11.5K
TIL icon
40
Instil Bio
TIL
$50.3M
$12.1M 0.89%
33,959
-8,682
-20% -$3.24M
MXCT icon
41
MaxCyte
MXCT
$126M
$12M 0.87%
+980,122
New +$14.8M
BILL icon
42
BILL Holdings
BILL
$4.78B
$11.9M 0.87%
44,687
+2,694
+6% +$622K
ARNA
43
DELISTED
Arena Pharmaceuticals Inc
ARNA
$11.9M 0.87%
199,410
-98,837
-33% -$5.84M
GH icon
44
Guardant Health
GH
$22.6B
$11.8M 0.86%
94,363
-32,860
-26% -$3.9M
OSH
45
DELISTED
Oak Street Health, Inc.
OSH
$11.8M 0.86%
276,596
-106,794
-28% -$5.74M
EXAS
46
DELISTED
Exact Sciences
EXAS
$11.3M 0.82%
118,259
-54,909
-32% -$5.8M
CVX icon
47
Chevron
CVX
$366B
$11.2M 0.81%
110,000
– –
SDGR icon
48
Schrodinger
SDGR
$1.36B
$11M 0.8%
201,513
-67,681
-25% -$4.33M
CALY
49
Callaway Golf Company
CALY
$3.14B
$11M 0.8%
398,539
-93,075
-19% -$2.83M
FIVN icon
50
FIVE9
FIVN
$2.54B
$10.5M 0.76%
65,518
+2,370
+4% +$432K
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Nicholas Investment Partners held 216 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $309M in Q3 2021, closing 28 positions and reducing 53 holdings. Its most notable exit was Zai Lab, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Ginkgo Bioworks worth $27.6M.

  • Nicholas Investment Partners's largest Q3 2021 buy was Ginkgo Bioworks: 59,532 shares worth $27.6M.
  • Nicholas Investment Partners added most to Expand Energy Corp in Q3 2021, an estimated $7.8M increase.
  • Nicholas Investment Partners's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.2M.
  • Nicholas Investment Partners fully exited Zai Lab in Q3 2021, selling an estimated $25.1M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.37B portfolio in Q3 2021.
  • Nicholas Investment Partners opened 21 new positions and closed 28 in Q3 2021.
  • Nicholas Investment Partners's portfolio value fell 14% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.